Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19

INTRODUCTION: the current worldwide outbreak of Coronavirus disease 2019 (COVID-19) due to a novel coronavirus (SARS-CoV-2) is seriously threatening the public health. The number of infected patients is continuously increasing and the need for Intensive Care Unit admission ranges from 5 to 26%. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Chong, Su, Binxiao, Dong, Hailong, Fakhr, Bijan Safaee, Grassi, Luigi Giuseppe, Di Fenza, Raffaele, Gianni, Stefano, Pinciroli, Riccardo, Vassena, Emanuele, Morais, Caio Cesar Araujo, Bellavia, Andrea, Spina, Stefano, Kacmarek, Robert, Berra, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239076/
https://www.ncbi.nlm.nih.gov/pubmed/32511450
http://dx.doi.org/10.1101/2020.03.10.20033522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239076/
https://www.ncbi.nlm.nih.gov/pubmed/32511450
http://dx.doi.org/10.1101/2020.03.10.20033522

Ejemplares similares